Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 29;12(1):7058.
doi: 10.1038/s41598-022-11238-0.

Parathyroid venous sampling for the preoperative localisation of parathyroid adenoma in patients with primary hyperparathyroidism

Affiliations

Parathyroid venous sampling for the preoperative localisation of parathyroid adenoma in patients with primary hyperparathyroidism

Joon Ho et al. Sci Rep. .

Abstract

Preoperative localisation studies are essential for parathyroidectomy in patients with primary hyperparathyroidism. If the location of abnormal parathyroid glands cannot be identified through non-invasive studies, parathyroid venous sampling (PVS) may be employed. In this study, we evaluated the utility of preoperative PVS in parathyroid surgery. Patients with primary hyperparathyroidism who underwent preoperative PVS at Severance Hospital between January 2015 and June 2020 were identified. Patients for whom the results of non-invasive imaging studies were inconsistent or negative underwent PVS. The results of PVS were compared with operative findings and pathologic results. For 14 patients, the results of preoperative ultrasonography and 99mTc-sestamibi single-photon emission computed tomography (SPECT) were negative; for 20 patients, either the result of only one test was positive, or the results of the two tests were inconsistent. With respect to the lateralisation of diseased adenoma, the results of PVS and pathological examination were inconsistent only for one patient in either group (total: 2/34 patients). This study showed that PVS could be used effectively for preoperative localisation in patients with primary hyperparathyroidism in whom the location of diseased parathyroid glands cannot be determined through non-invasive image studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow-chart describing the inclusion of patients and the study population; MEN: Multiple endocrine neoplasia, PHPT: primary hyperparathyroidism, PTH: parathyroid hormone, PVS: parathyroid venous sampling, US: ultrasonography, SPECT: single-photon emission computed tomography.

Similar articles

Cited by

References

    1. Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391:168–178. doi: 10.1016/S0140-6736(17)31430-7. - DOI - PubMed
    1. Horiuchi K, et al. Impact of "Tailored" parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. World J. Surg. 2018;42:1772–1778. doi: 10.1007/s00268-017-4366-z. - DOI - PubMed
    1. Pallan S, Rahman MO, Khan AA. Diagnosis and management of primary hyperparathyroidism. BMJ. 2012;344:e1013. doi: 10.1136/bmj.e1013. - DOI - PubMed
    1. Gasser RW. Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med. Wochenschr. 2013;163:397–402. doi: 10.1007/s10354-013-0235-z. - DOI - PubMed
    1. Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist. 2007;12:644–653. doi: 10.1634/theoncologist.12-6-644. - DOI - PubMed

MeSH terms

Substances